These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9054900)

  • 21. Reference dose rates for single- and double-plane 192Ir implants.
    Saw CB; Suntharalingam N
    Med Phys; 1988; 15(3):391-6. PubMed ID: 3405143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An adjustable breast bridge for use in multiple-plane interstitial breast implants.
    Johnson DW
    Br J Radiol; 1984 Feb; 57(674):159-61. PubMed ID: 6692086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Planning of Ir-192 seed implants for boost irradiation to the breast.
    Zwicker RD; Schmidt-Ullrich R; Schiller B
    Int J Radiat Oncol Biol Phys; 1985 Dec; 11(12):2163-70. PubMed ID: 4066449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison.
    Perez CA; Taylor ME; Halverson K; Garcia D; Kuske RR; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):995-1007. PubMed ID: 8600112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of dose-rate and dose per fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants: analysis of 289 cases.
    Deore SM; Sarin R; Dinshaw KA; Shrivastava SK
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):601-6. PubMed ID: 8330988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose-rate brachytherapy as the sole radiation modality in the management of patients with early-stage breast cancer treated with breast-conserving therapy: preliminary results of a pilot trial.
    Vicini FA; Chen PY; Fraile M; Gustafson GS; Edmundson GK; Jaffray DA; Benitez P; Pettinga J; Madrazo B; Ingold JA; Goldstein NS; Matter RC; Martinez AA
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):301-10. PubMed ID: 9226316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between continuous and discrete sources in the Paris system of implants.
    Paul JM; Philip PC; Brandenburg RW; Koch RF
    Med Phys; 1989; 16(3):414-24. PubMed ID: 2739623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose and volume effects on fibrosis after breast conservation therapy.
    Borger JH; Kemperman H; Smitt HS; Hart A; van Dongen J; Lebesque J; Bartelink H
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1073-81. PubMed ID: 7961014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. External beam irradiation plus (192)Ir implant after breast-preserving surgery in women with early breast cancer.
    Moreno F; Guedea F; Lopez Y; Ferrer F; Gutierrez C; Petriz L; Pera J
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):757-65. PubMed ID: 11020573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consequences of optimization in PDR brachytherapy--is a routine geometrical optimization recommendable?
    Berns C; Fritz P; Hensley FW; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1171-80. PubMed ID: 9169828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose specification and quality assurance of radiation therapy oncology group protocol 95-17; a cooperative group study of iridium-192 breast implants as sole therapy.
    Ibbott GS; Hanson WF; O'Meara E; Kuske RR; Arthur D; Rabinovitch R; White J; Wilenzick RM; Harris I; Tailor RC
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1572-8. PubMed ID: 18035213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system?
    Nickers P; Lenaerts E; Thissen B; Deneufbourg JM
    Radiother Oncol; 2005 Feb; 74(2):131-6. PubMed ID: 15734200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
    Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose uniformity in a planar interstitial implant system.
    Zwicker RD; Schmidt-Ullrich R
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):149-55. PubMed ID: 7995746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Method of localization and implantation of the lumpectomy site for high dose rate brachytherapy after conservative surgery for T1 and T2 breast cancer.
    Perera F; Chisela F; Engel J; Venkatesan V
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):959-65. PubMed ID: 7860412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative implantation of iridium-192 as the boost technique for stage I and II breast cancer: results of a 10-year study of 655 patients.
    Mansfield CM; Komarnicky LT; Schwartz GF; Rosenberg AL; Krishnan L; Jewell WR; Rosato FE; Moses ML; Barbot D; Cohn HE
    Radiology; 1994 Jul; 192(1):33-6. PubMed ID: 8208960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First clinical experience with a remote afterloading system for low dose rate interstitial breast implants.
    Meertens H; Bartelink H; Minderhoud T
    Radiother Oncol; 1988 Apr; 11(4):387-93. PubMed ID: 3375463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study.
    Pantelis E; Papagiannis P; Karaiskos P; Angelopoulos A; Anagnostopoulos G; Baltas D; Zamboglou N; Sakelliou L
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1596-602. PubMed ID: 15817368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High beta and electron dose from 192Ir: implications for "gamma" intravascular brachytherapy.
    Patel NS; Chiu-Tsao ST; Ho Y; Duckworth T; Shih JA; Tsao HS; Quon H; Harrison LB
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):972-80. PubMed ID: 12377352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.